Form 4: Inari Medical CFO Mitch Hill Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Inari Medical's CFO, Mitch C. Hill, exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.
Summary
- On September 12, 2024, Mitch C. Hill, the Chief Financial Officer of Inari Medical, Inc., executed stock options to acquire 3,000 shares of common stock at a price of $0.457 per share.
- Concurrently, Hill sold 1,609 shares at a weighted average price of $44.38, 891 shares at a weighted average price of $45.8, and 500 shares at a weighted average price of $46.34.
- These transactions were conducted under a Rule 10b5-1 trading plan adopted on November 9, 2023.
- Following these transactions, Hill directly owns 179,600 shares of Inari Medical common stock and indirectly owns 1,600 shares through his spouse.
- He also holds options to purchase 58,477 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing related to stock transactions by an executive under a pre-arranged plan. While insider sales can sometimes raise concerns, the 10b5-1 plan mitigates this.
Positives
- The transactions were executed under a pre-existing Rule 10b5-1 trading plan, which can be viewed as a structured and transparent approach to stock sales.
Risks
- Executive stock sales, even under a 10b5-1 plan, can sometimes be perceived negatively by investors, potentially creating short-term price volatility.
Future Outlook
The document does not contain specific forward-looking statements about the company's future performance.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. The use of a 10b5-1 plan is a common practice to avoid accusations of insider trading.
Comparison to Industry Standards
- Executive compensation packages often include stock options as incentives.
- The vesting schedule of the options (25% initially, then monthly installments) is a typical arrangement.
- The use of 10b5-1 trading plans is a standard practice among executives to manage stock sales.
Stakeholder Impact
- The stock sales could have a minor short-term impact on shareholders due to potential price fluctuations.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2020-04-30 | Options vested with respect to 25% of the shares. |
| 2023-11-09 | Date the reporting person adopted the Rule 10b5-1 trading plan. |
| 2024-09-12 | Date of the reported transactions: exercising options and selling shares. |
| 2024-09-13 | Date of the Form 4 filing. |
| 2029-04-23 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.